Application
Fig1: Western blot analysis of VIMP on human VIMP recombinant protein using anti-VIMP antibody at 1/1,000 dilution.Application
Fig2: Western blot analysis of VIMP on HEK293 (1) and VIMP-hIgGFc transfected HEK293 (2) cell lysate using anti-VIMP antibody at 1/1,000 dilution.Application
Fig3:Western blot analysis of VIMP on different cell lysate using anti-VIMP antibody at 1/1,000 dilution. Positive control： Lane1: MCF-7 Lane2: PANC-1 Lane3: Jurkat Lane4: HepG2 Lane5: MOLT4 Lane6: U251 Lane7: A431Application
Fig4: Immunohistochemical analysis of paraffin-embedded human rectum cancer tissue using anti-VIMP antibody. Counter stained with hematoxylin.Application
Fig5: Immunohistochemical analysis of paraffin-embedded human endometrial cancer tissue using anti-VIMP antibody. Counter stained with hematoxylin.| Product Name | VIMP [G1-F8] |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | AD-015 antibody ADO15 antibody MGC104346 antibody MGC2553 antibody SBBI8 antibody selenoprotein S antibody SEPS1 antibody VCP interacting membrane protein antibody VCP-interacting membrane antibody VIMP antibody |
| Product description | Selenium is an essential trace element that is incorporated as selenocysteine into the primary structure of Selenoproteins. Nutritional deficiency of selenium decreases Selenoprotein concentrations and leads to pathologic conditions. Most of the known Selenoproteins are members of the glutathione peroxidase or iodothyronine deiodinase families. Selenoprotein S, also known as VIMP or SELS, is a 189 amino acid single-pass membrane protein that localizes to the endoplasmic reticulum (ER) and contains a selenocysteine (Sec) residue at its active site. Interacting with Derlin-1 and VCP, Selenoprotein S is involved in the degradation of misfolded ER proteins, specifically participating in the transfer of misfolded proteins from the ER to the cytosol for subsequent proteasomal degradation. Aberrant expression of Selenoprotein S is associated with diabetes, cardiovascular disease and rheumatoid arthritis. |
| Immunogen | Recombinant protein |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG2b |
| Host Species | Mouse |
| Tested Applications | WBIHC |
| WB:1:500-1:2,000 IHC:1:100-1:200 |
|
| Species Reactivity | Human |
| Concentration | 2mg/ml |
| Alternative Names | AD-015 antibody ADO15 antibody MGC104346 antibody MGC2553 antibody SBBI8 antibody selenoprotein S antibody SEPS1 antibody VCP interacting membrane protein antibody VCP-interacting membrane antibody VIMP antibody |
|---|---|
| Molecular Weight(MW) | 21 kDa |
| Cellular Localization | Endoplasmic reticulum membrane. Cytoplasm. |
| SwissProt ID | Q9BQE4 |
|---|
Application
Fig1: Western blot analysis of VIMP on human VIMP recombinant protein using anti-VIMP antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of VIMP on HEK293 (1) and VIMP-hIgGFc transfected HEK293 (2) cell lysate using anti-VIMP antibody at 1/1,000 dilution.
Application
Fig3:Western blot analysis of VIMP on different cell lysate using anti-VIMP antibody at 1/1,000 dilution. Positive control： Lane1: MCF-7 Lane2: PANC-1 Lane3: Jurkat Lane4: HepG2 Lane5: MOLT4 Lane6: U251 Lane7: A431
Application
Fig4: Immunohistochemical analysis of paraffin-embedded human rectum cancer tissue using anti-VIMP antibody. Counter stained with hematoxylin.
Application
Fig5: Immunohistochemical analysis of paraffin-embedded human endometrial cancer tissue using anti-VIMP antibody. Counter stained with hematoxylin.| Positive Control | Human VIMP recombinant protein, VIMP-hIgGFc transfected HEK293 cell lysate, MCF-7, PANC-1, Jurkat, HepG2, MOLT4, U251, A431, human rectum cancer, human endometrial cancer. |
|---|---|
| Application Notes | WB:1:500-1:2,000 IHC:1:100-1:200 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
